A prospective observational study reported that approximately 19.4% of all patients with LS carry a pathogenic MSH6 mutation, with the cumulative prevalence of EC in 65-year-old carriers reaching 32.1% [53]. The gene discussed is MSH6; the disease is Leigh syndrome.